IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today FDA 510 (k) clearance and full market release of Rad-97™ Pulse CO-Oximeter ®, including configurations with integrated NomoLine™ ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Masimo has received FDA 510(k) clearance and market release of Rad-97™ Pulse CO-Oximeter. This includes configurations with the integrated NomoLine™ capnography and noninvasive blood pressure (NIBP) ...

Oct 6 (Reuters) - Masimo Corp : * Masimo announces CE marking of Rad-97(TM) pulse co-oximeter Source text for Eikon: Further company coverage: Masimo CorpShs NewsMORE Related Stocks Indices ...

Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the ...

Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter. The Rad-G is a handheld device that combines Masimo’s ...

Masimo Corporation MASI received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises Measure-through ...

The "Pulse Oximeters - Global Strategic Business Report" report has been added to Research and Markets' offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe ...

The maker of non-invasive monitoring technologies reported a record quarter, thanks to solid sales growth of its SET pulse oximetry products. Masimo announced its 2018 first-quarter results after the ...

Rugged Handheld Device Provides Clinically Proven Masimo SET® Pulse Oximetry and Respiration Rate Monitoring IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today FDA clearance of ...

Masimo, a global medical technology company, announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp on ...